ERILF yields 20000.00% · PFE yields 6.20%● Live data
📍 ERILF pulled ahead of the other in Year 1
Combined, ERILF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ERILF + PFE for your $10,000?
Dynamic Technologies Group Inc. designs, builds, and installs entertainment attractions and ride systems for the entertainment industry. The company operates through Ride Systems Manufacturing, and Parts and Service segments. It also applies turn-key integration services for special projects, such as alternative energy, large optical telescopes, and enclosures, as well as custom steel fabrication services. In addition, the company provides custom design-build-commission services for custom ride systems and attractions, as well as parts and services to park operators for its own ride systems and those ride systems supplied by others. Further, it owns and operates the SkyFlyTM Soar America flying theater attraction at the Island in Pigeon Forge theme park in Tennessee; provides design engineering and product research and development services for complex ride systems; and designs integrated structures, such as astronomical telescope enclosures for third party customers. The company serves theme parks, stand-alone tourist venues, and the government sector in Canada, the United States, Asia, the Middle East, and Europe. The company was formerly known as Empire Industries Ltd. and changed its name to Dynamic Technologies Group Inc. in March 2021. Dynamic Technologies Group Inc. was founded in 1926 and is headquartered in Toronto, Canada.
Full ERILF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.